ARTH Financials 07/16/2014 14:58:14 Arch Therapeu

ARTH Financials 07/16/2014 14:58:14
Arch Therapeutics, Inc.
Period Ending Sep 30, 2013 Sep 30, 2012 Sep 30, 2011
Total Revenue - - -
Cost of Revenue - - -
Gross Profit - - -
Operating Expenses
Research and Development 219 87 -
Sales, General and Admin. 1,526 334 5
Non-Recurring Items - - -
Other - - -
Operating Income (1,745) (421) (5)
Income From Continuing Operations
Add'l Income/Expense Items - - -
Earnings Before Interest and Tax (1,745) (420) (5)
Interest Expense 109 157 -
Earnings Before Tax (1,854) (577) (5)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (1,854) (577) (5)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (1,854) (577) (5)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (1,854) (577) (5)